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Impairment by cyciosporine of membrane-mediated functions in kidney
mitochondria. This study was performed to evaluate whether cyclospo-
rine penetrates kidney mitochondria and impairs mitochondrial func-
tions, causing nephrotoxicity. Exposure of rat kidney cortical mitochon-
dria in vitro to cyclosporine had little effect on the oxidation of
glutamate plus malate. Oxidation of succinate was markedly inhibited
by a toxic level of cyclosporine (25 to 50 nmol/mg protein) under resting
(State 4) and ADP-stimulated (State 3) conditions, Under uncoupling
conditions, induced by the proton ionophore, CCCP or by the calcium
ionophore, A23 187 plus calcium, mitochondrial respiration was un-
changed by cyclosporine. In mitochondria isolated from rats treated
with an immunosuppressive dose of cyclosporine (25 mg/kg/day, p.o.),
respiration was not significantly impaired. The respiration stimulated by
ADP was only diminished in mitochondria from rats treated with 75
mg/kg. The rate of calcium uptake was unchanged by cyclosporine
under in vitro and in vivo conditions. Kidney mitochondria of untreated
rats maintained in a medium containing respiratory substrates and
phosphate released spontaneously accumulated calcium that was ac-
companied by large amplitude swelling and enhanced respiration.
Cyclosporine in vitro inhibited the process of spontaneous calcium
discharge at the concentration range of 0.1 to 0.5 nmol/mg protein.
Swelling and respiration induced by accumulated calcium was signifi-
cantly diminished in kidney mitochondria isolated from cyclosporine-
treated rats given doses of 25 or 75 mg/kg. The data obtained indicate
that cyclosporine interacts with the membrane of kidney mitochondria
in virtually the same way under in vitro and in vivo conditions.
Cyclosporine at an immunosuppressive level impairs calcium-induced
membrane permeability and at a toxic level, the rate of ADP phospho-
rylation.
plasma membrane permeability or the interference with cellular
energy derived from mitochondria [7—9].
In the kidneys of cyclosporine-treated animals, histological
findings were most obvious in the proximal tubules and in-
cluded varying degrees of cytosolic vacuolization, formation of
myeloid bodies and evidence of autophagocytosis of mitochon-
dna [3, 6, 101. In a renal transplant removed from a patient
treated with cyclosporine, mitochondria showed a decreased
level of mitochondrial F1-ATPase [11]. Structural abnormalities
of mitochondria may arise from alterations in mitochondrial
biogenesis or from defective mitochondrial functions due to the
direct effect of cyclosporine. It has been reported that in vitro
exposure of isolated rat kidney mitochondria to cyclosporine
results in uncoupling of the mitochondrial membrane and inhi-
bition of succinate oxidation [12, 13]. No studies, however,
addressed the issue as to whether cyclosporine administration
in vivo to rats has any effect on mitochondrial respiration.
The purpose of this study was to evaluate whether cyclospo-
rine nephrotoxicity might be related to mitochondrial dysfunc-
tion, and to compare the direct effect of cyclosporine in vitro to
its effect in vivo on the membrane-mediated functions of kidney
mitochondria.
Methods
Animal experiments
Cyclosporine, a fungal peptide with unique immunosuppres-
sive action, is known to exhibit adverse side effects upon a
variety of organs [1—3]. Nephrotoxicity appears to be the most
significant side effect of cyclosporine, and the proximal tubules
are the main site of cyclosporine action. The extent of kidney
dysfunction induced by cyclosporine varies and generally oc-
curs at doses within the immunosuppressive range for a given
species [3—6]. The cellular mechanism of cyclosporine nephro-
toxicity is unknown. Drug-induced renal failure may be related
to an alteration in renal hemodynamics or to damage of renal
tubular cells. Of these two processes, direct cell injury is
thought to be the major cause of drug-related acute renal
failure. Proposed mechanisms involve either the alteration of
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Male Sprague-Dawley rats weighing 250 to 300 g were used.
Experiments in vitro were performed on kidney cortical mito-
chondria isolated from untreated animals. Cyclosporine in
ethanol solution was introduced into the mitochondrial suspen-
sion in the amounts indicated in the figure legends. A corre-
sponding amount of ethanol, 3 to 10 p.l, was added to the
incubation medium of the controls. To study the effects of
cyclosporine in vivo, the drug was administered by gavage in
doses of 25 and 75 mg/kg to two groups of rats for seven days.
Control animals received an olive oil vehicle. The rats were
given food and water at libitum. Body weights were measured
at the beginning and the end of the experiment.
Mitochondrial preparation
Rat kidney mitochondria were isolated using the standard
procedure of differential centrifugation [14]. After cervical
dislocation, the abdomen was opened, the kidneys were re-
moved and placed in an ice-cold solution of 225 mrvi mannitol,
m sucrose, 0.05 mM EGTA and 5 mrvi MOPS-buffer, at pH
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7.2. The renal cortex was separated from the medulla with a
scalpel, minced and homogenized using a Potter-Elvehjem
homogenizer. Unbroken cells and nuclei were sedimented at
600 x g for five minutes in a refrigerated Beckman centrifuge.
Mitochondna were separated from the supematant by centrif-
ugation at 15,000 x g for 10 minutes, rinsed and finally
resuspended in a similar medium without EGTA.
Respiration of mitochondria
The respiration rate of mitochondria was determined by
measuring oxygen consumption polarographically with a Clark
electrode at 28°C in a medium containing 135 mM KC1, 20 mM
MOPS-buffer, 5 mai K2HPO4, 1 mM MgCl2 and 0.1 mM EGTA,
pH 7.2 with 10 m glutamate plus 2 mM malate or 10 mM
succinate plus 2 tg/m1 rotenone. In some experiments, the
incubation medium was used without magnesium ions and 0.1
mM EGTA was replaced with 0.5 mrvi EDTA. When used,
calcium ionophore A23 187 was 3 nmol/mg and the uncoupling
agent carbonyl cyanide m-chlorophenylhydrazone (CCCP) was
0.5 M [15, 16]. Respiration of mitochondria with the reduced
form of tetramethyiphenylenediamine (TMPD) was measured in
the medium containing 2 g/ml rotenone, 0.3 g/ml antimycin
A, 0.5 M CCCP, 1.2 m NADH plus 0.1 mri TMPD. The
system of TMPD plus NADH was used at one-third of its
maximal efficiency rather than the less efficient system of
TMPD plus ascorbate [17]. The concentration of mitochondrial
protein was in the range of 0.85 to 0.95 mg/mi. The calculations
of oxygen consumption were done using standard procedures
[18].
Spontaneous calcium discharge
The process of spontaneous calcium discharge from mito-
chondria was measured in two incubation media: 200 mM
mannitol plus 75 m sucrose or 140 mM KCI. Both contained 20
m MOPS-buffer, pH 7.2, 2 mM K2HPO4, 10 m potassium
succinate and 2 sg/ml rotenone at 28°C [19, 20]. After 40
seconds of preincubation of mitochondria (0.5 to 0.6 mg/ml), the
process was initiated by adding 57 nmol/ml CaCI2 and followed
as indicated in the figures. In preliminary experiments, the
optimal amount of calcium to add was determined to be in the
range of 100 to 120 nmol/mg of mitochondrial protein. This
concentration gave optimal time resolution and magnitude of
mitochondrial response. Swelling of mitochondria was quanti-
tated as a decrease in optical density in a Beckman spectropho-
tometer at 540 nm. Respiration of mitochondria was determined
polarographically in a parallel incubation. Calcium levels of the
mitochondrial suspending media were determined with a Ca +
selective electrode (Corning electrodes, adapted to incubation
cell) and calibrated by additions of standard solutions of CaC12.
Materials
Cyclosporin A was from Sandoz (E. Hanover, New Jersey,
USA). Dibucaine, verapamil and all substrates and metabolic
inhibitors were from Sigma Chemical Company (St. Louis,
Missouri, USA).
Statistics
All results represent the measurements from at least four
separate experiments. Some data depict recording traces of
non-linear or transient responses of mitochondria from individ-
Cycosporine nmol/mg protein
Fig. 1. Effect of cyclosporine in vitro on respiration of kidney mitochon-
dna. The respiration rate (solid lines) and the ADP/O ratio (dotted line)
were measured with 10 m glutamate plus 2 ms malate (closed
squares) or 10 msi succinate plus rotenone (closed circles) in a standard
incubation medium. Data represents the mean SEM from 5 experi-
ments. *D < 0.05 vs. control.
ual experiments. Statistical analyses were performed using the
Student's unpaired t-test. Differences were considered statisti-
cally significant at P < 0.05.
Results
In vitro effect of cyclosporine on respiration of mitochondria
The addition of cyclosporine in increasing amounts to the
mitochondrial suspension did not affect the oxidation of gluta-
mate pius malate by mitochondria under resting (state 4)
conditions (Fig. 1). Oxidation of succinate was significantly
inhibited by cyclosporine at 25 and 50 nmollmg protein. Phos-
phorylation of ADP, represented by the ADP/O ratio, remained
unchanged with both sets of substrates. The respiration of
mitochondria with glutamate pius malate was inhibited in the
presence of ADP (Table 1). At doses of 50 nmol/mg of cyclo-
sporine, respiration with glutamate plus malate was lowered by
12% and with succinate by 46%. The acceptor-control indices
(ACI) were also decreased at the highest doses of cyclosporine
and were 21% and 16% lower in comparison to the control
values, respectively.
Table 2 shows mitochondrial respiration with a variety of
substrates that provide electrons to different segments of the
mitochondrial electron transport chain. Oxidation of glutamate
plus malate supplies electrons via NAD, succinate oxidation
provides electrons via coenzyme Q and TMPD shuttles elec-
trons to cytochrome oxidase via cytochrome c. Cyclosporine in
vitro did not affect the respiration of uncoupled mitochondria in
the presence of all sets of substrates.
The inhibitory pattern of cyclosporine was similar for suc-
cinate oxidation by mitochondria in medium with (Table 1) or
without magnesium ions (Table 3). In Table 3, the values of the
respiration stimulated by ADP were calculated over the respi-
ration in the absence of ADP. In this way, the combined rate of
ADP transport into the mitochondrial matrix and its phosphor-
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Table 1. Eifect of cyclosporine on the respiration of rat kidney cortical mitochondria in vitro
.
Experimental
conditions
Glutamate plus malate Succinate
State 4 State 3
AC!
State 4 State 3
AC!natom 02 X mi,F' X mg' natom 02 X min''>< mg'
Control
Cyclosporiae
S nmol/mg
25 n,nol/mg
50 nmol/mg
28.9 1.2
33.0 2.0
34.0 2.9
37.5 1.3
270 7
267 8
241 12238 8
4.68 0.24
4.32 0.08
3.78 o.or
3.68 0.07a
74.9 1.9
69.9 3.7
54.9 2.Sa
54.1 4,5k
398 18
352 8
229 26221 l8
3.55 0.23
3.35 0.26
2.88 0.20
2.90 0.09k
The rate of oxygen consumption by mitochondria was determined in the absence of ADP (state 4) and in the presence of ADP (state 3) in a stan-
dard incubation medium. AC!, the acceptor control index is the ratio of the respiration rate of mitochondria in the presence of ADP to the
respiration rate when all added ADP has been phosphorylated. Data represent means 5EM from 4 to S experiments.
a P C 0.05vs. control.
Table 2. Effect of cyclosporin A on electron flow in separate
segments of the mitochondrial electron transport chain in vitro
Experimental
conditions
NADH-*02 cyt.Q-*02 cyt.c—*02
natom 02 X mg' X mm -J
Control 254 8 550 20 197 6
Cyclosporine
5 nmol/mg 243 14 539 19 218 7
25 nmol/mg 246 15 487 32 209 3
50 nmol/mg 243 13 496 24 198 9
Data represent means SEM from4 to S experiments. Abbreviations
are: NADH—÷02, oxidation of glutamate plus malate; cyt.Q—*02,
oxidation of succinate; cyt.c-.02, oxidation of the reduced form of
tetramethylphenylenediamine (TMPD). The incubation conditions are
presented in Methods.
ylation was reflected. Cyclosporine markedly inhibited the
ADP-stimulated respiration at a comparable level in a medium
with or without magnesium.
Table 3 shows the respiration rate of mitochondria stimulated
by the dissipated cycling of calcium across the mitochondrial
membrane. The calcium ionophore, A23 187, allows calcium
being accumulated in mitochondria to leak out, resulting in
steady-state cycling. Under experimental conditions with a
limited amount of calcium, the respiration rate of mitochondria
is an indirect measure of the rate of calcium transport into the
mitochondrial matrix. At a saturated level of calcium, the
respiration stimulated by cycling calcium becomes limited in
kidney mitochondria by the rate of substrate supplied to the
respiratory chain [16, 21]. Cyclosporine in vitro had no effect on
the respiration rate of mitochondria stimulated over the basal
rate by the presence of calcium ionophore at either a low or
saturated level of calcium.
In vivo effects on respiration
Table 4 shows the respiration of kidney cortical mitochondria
isolated from cyclosporine-treated rats. A low-dose of cyclo-
sporine (25 mg/kg) had no effect on the respiration of mitochon-
dna with glutamate plus malate or succinate. Mitochondria
isolated from cyclosporine-treated rats given a dose of 75 mg/kg
exhibited significantly lower ADP-stimulated respiration in com-
parison to the placebo-treated animals. Respiration of mitochon-
dria with glutamate plus malate decreased by 23% and with
succinate by 24%. The acceptor-control indices were also
Table 3. Effect of cyclosporine in vitro on the stimulation by ADP
and calcium ionophore of mitochondrial respiration
A2318? + Ca'4'4'
None ADP
—70 MM —250 MM
Additions natom 02>( mm X mg'
--
Control 93.7 4.7 322 14 98.3 7.9 308 6
Cyclosporine
5 nmol/mg 79.0 2.0 274 15 102.2 2.7 325 5
25 nmol/mg 62.3 S2 206 6 82.8 4.4 335 8
SO nmol/mg 62.1 4.7" 175 5" 82.9 4.5 326 7
Means SEM from 4 experiments.
a Stimulation calculated over state 4 respiration (no additions).
Incubation medium was without magnesium ions and with succinate
plus rotenone, as described in Methods.
"P C 0.05 vs. control.
decreased by 22% and 17%, respectively. The ADP/0 ratios
were unchanged.
The ADF-stimulated respiration of mitochondnia after 75
mg/kg cyclosporine treatment was decreased to the same extent
in a medium with (Table 4) or without magnesium (Table 5).
Calcium uptake was not inhibited in kidney mitochondi-ia
isolated from cyclosponine-treated rats. In control mitochon-
dria, at a low level of calcium, the respiration rate was stimu-
lated by A23 187 over state 4 respiration by 126 5 natom
02/mg/min. The corresponding value for 75 mg/kg cyclosponine-
treated rats was 124 8 natom 02/mg/min (Table 5). Respiration
of uncoupled mitochondria was unchanged with all sets of
substrates tested (data not shown).
Spontaneous calcium discharge, effects in vitro
Figure 2 shows calcium movement, swelling and respiration
of kidney mitochondria maintained in maanitol-sucrose medium
under the experimental conditions of spontaneous calcium
discharge [20, 21]. After accumulation of calcium, mitochondnia
released it with subsequent re-uptake. As calcium ions circu-
lated across the mitochondrial membrane, there was significant
swelling and enhanced respiration of mitochondnia [22, 23].
Exhaustion of oxygen in the medium by mitochondnia resulted
in additional swelling and in massive release of calcium. Figure
2 represents the recording traces obtained in one of the four
separate experiments. In all experiments, cyclosporine inhib-
ited mitochondrial swelling, respiration and transient calcium
release in the concentration range of 0. ito 0.5 nmol/mg protein.
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Table 4. The respiration rate of kidney cortical mitochondna isolated from cyclosporin A-treated rats
.
Experimental
conditions
None ADP CCCP
AC! ADP/Onatoms 02 x mg' x mm -'
Glutamate, malate
Control 33.2 1.8 284 15 277 23 4.64 0.16 2.39 0.06
CsA 25 mg/kg 28.5 1.2 271 6 255 10 4.67 0.27 2.15 0.03
CsA 75 mg/kg 35.8 2.0 219 i7 230 30 3.63 0.34a 2.47 0.06
Succinate
Control 80.8 4.5 416 11 527 12 3.69 0,16 1.53 0.06
CsA25 mg/kg 70.0 3.4 390 12 493 20 3.65 0.14 1.41 0.09
CsA 75 mg/kg 73.5 4.4 324 l8 504 23 3.05 o.2o 1.67 0.05
Data represent means SEM from 6 experiments. Abbreviations are: AC!, the acceptor control index; CsA, cyclosporine-treated rats with the
oral doses of 25 or 75 mg/kg of body weight daily for one week.
a P < 0.05 vs. control
Table 5. Stimulation of the mitochondrial respiration by ADP and
calcium ionophore in kidney mitochondria isolated from
cyclosporine-treated rats
A23187 + Ca
None ADP —P80 M —250 M
Additions natom 02 X mm )< mg -'
Control 98.1 9.1 313 15 126 5 320 10
CsA 25 mg/kg 78.4 2.2 292 16 127 17 341 8
CsA 75 mg/kg 87.8 5.7 251 24" 124 8 318 17
Data represent means SEM from 6 experiments.
a Measurements and calculations were done as described in the
legend of Table 3.
b P < 0.05 vs. control
Calcium uptake by mitochondria was not inhibited by cyclo-
sporine.
Calcium uptake and discharge by mitochondria, effects
in vivo
To quantitate the in vivo effect of cyclosporine on the
phenomenon of spontaneous calcium discharge by mito-
chondria, the rates of maximal swelling and respiration of
mitochondria were measured. Table 6 shows that both pro-
cesses were significantly diminished. Swelling of mitochondria
was inhibited more strongly than respiration. Calcium uptake to
trigger swelling was not impaired. The transient release of
accumulated calcium by energized mitochondria was partially
inhibited after low dose cyclosporine treatment (25 mg/kg) and
completely blocked after high dose treatment (75 mg/kg), (data
not shown).
Inhibitors of calcium-induced swelling of mitochondria
The pronounced swelling and release of calcium was similar
in both KCI-medium (Figs. 3 and 4) and mannitol-sucrose
medium (Fig. 2). Cyclosporine in vitro almost completely
inhibited mitochondrial swelling in KC1-medium at a concentra-
tion of 2.2 X iO M (equivalent to 0.4 nmol/mg protein under
this experimental condition). Verapamil and dibucaine inhibited
calcium-induced swelling of kidney mitochondria at concentra-
tions of !0- M and lO— M that are comparable to those
reported for liver mitochondria [24]. These concentration
ranges are higher by three orders of magnitude than the
inhibition range of cyclosporine. The enhanced respiration of
A Ca2 release
100 natoms 021m1
Control 0.08
Fig. 2. Effect of cyclosporine (CsA) in vitro on the process of sponta-
neous calcium discharge. Rat kidney cortical mitochondria (0.55
mg/ml) were maintained in a mannitol-sucrose medium with 10 mi
succinate and 2 mii K2HPO4. Cyclosporine was introduced into mito-
chondrial suspension and followed by an addition of 57 M CaC12.
Calcium level (A), optical density (B) and oxygen content (C) of the
mitochondrial suspension were measured in parallel samples. Record-
ing traces are shown from one of the four separate experiments.
mitochondria, accompanied by swelling, was further activated
by verapamil and dibucaine, and exhaustion of oxygen occurred
earlier than with cyclosporine, resulting in massive calcium
I
Control
CsA
B
C
CaCI2
0.2
——**.
CsA
nmol/mg
0.08
CsA
nmo!/mg
I
1 mm
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Table 6. The rate of maximal swelling and respiration of kidney
mitochondria isolated from cyclosporin A-treated rats during
spontaneous calcium discharge
Respiration
SwellingExpenmental natoms 02 X mg
conditions 0D x mg' x min' X min'
Control 0.293 0.041 352 11
CsA2S mg/kg 0.168 0.04O 295 2l
CsA 75mg/kg 0.099 0,029a 216 27a
release (Fig. 4). The uptake of added calcium by renal
mitochondria was not affected by cyclosporine, verapamil nor
dibucaine (Fig. 4). In the experiment of Figure 4, verapamil and
dibucaine altered the resistance of the calcium selective elec-
trode, and the adjustment to the standard recording was done
graphically.
Discussion
Cyclosporine exhibits toxic effects not only on the kidney,
but also on other organs [2, 3, 9]. In the kidney, the proximal
tubules are mainly affected.
Morphological changes such as tubular inclusion bodies,
tubular vacuolization and grossly altered mitochondria were
seen in the rat kidney similar to those found in man although
less severe [6, 24]. An oral dose of 25 mg/kg cyclosporine is
reported to be immunosuppressive for this species and is
approximately three to five times that given to patients [4, 25,
26]. Alter multiple doses of 10 mg/kg to the rats, radiolabelled
cyclosporine accumulated in the renal tissue at 30 jzg/g, a level
10 times that found in the blood [271.
Cyclosporine in vitro at a concentration of up to 50 tg/ml,
corresponding in our study to 50 nmol/mg of mitochondrial
protein, had little effect on respiration of isolated mitochondria
with glutamate plus malate but significantly inhibited respira-
tion with succinate (Fig. 1). These data do not support the
findings of an uncoupling effect of cyclosporine [13]. Respira-
tion of mitochondria under resting conditions was not stimu-
lated and their ability to phorphorylate ADP, represented by the
ADP/O ratio, was not impaired. The discrepancy of changes in
mitochondrial functions between our studies and previous
studies may be related to the effect of sucrose present in the
incubation medium used in the earlier studies. In a sucrose
medium, mitochondria display lower succinate dehydrogenase
activity and lower rates of ADP-phosphorylation [281.
The fact that cyclosporine markedly suppressed respiration
of mitochondria with succinate may indicate an inhibitory effect
of cyclosporine on the activity of succinate dehydrogenase.
This, however, is unlikely because cyclosporine did not inhibit
respiration of mitochondria with succinate stimulated by the
uncoupler CCCP or by calcium ionophore plus an excess of
calcium (Tables 2 and 3). Under both experimental conditions,
the respiration rate was limited by the activity of succinate
dehydrogenase rather than by the rate of cycling of protons or
calcium across the mitochondrial membrane. An alternate
explanation is that cyclosporine may limit the electron flow into
noCa2
—
-—-- 23x105,,.,
-
S..-
-s5x10 M
Control
Fig. 3. Effect of cyclosporine, verapami! and dibucaine on calcium-
induced swelling of kidney mitochondria. Mitochondria (0.55 mg/mI)
were incubated in a KC1 medium with 10 thM succinate, 2 miw K2HPO4
and the compound as indicated. An addition of calcium (100 nmol/mg of
protein) is indicated by arrows. The figure represents the recording
traces obtained in one of the four separate experiments.
the energized mitochondrial membrane at the second site of
energy conservation. Ubiquinone (coenzyme Q)has been iden-
tified as a diffusion-mediated step between membrane dehydro-
genases and bc1 cytochromes [29]. Finally, cyclosporine may
have a direct inhibitory effect on the activity of the adenylate
carrier as well as on F1-ATP-ase.
The nephrotoxic action of cyclosporine has been frequently
compared and contrasted to the nephrotoxicity of gentamicin
[8, 26, 30]. It has been reported that gentamicin in vitro
uncouples the respiration of kidney mitochondria and impairs
electron flow into the respiratory chain. This inhibition is
markedly ameliorated by magnesium [31]. Moreover, the rate of
calcium uptake by mitochondria is decreased by gentamicin
[32]. In our experiments cyclosporine in vitro did not result in
uncoupling respiration or in inhibiting the electron flow in the
separate segments of the respiratory chain of mitochondria and
calcium uptake was unchanged.
The issue as to whether cyclosporine in vivo alters mitochon-
drial respiration has particular relevance, since its subcellular
compartmentalization has until now not been fully elucidated.
The pharmacokinetics of cyclosporine is very complicated and
the role of metabolites may be of importance in the pathogen-
esis of cyclosporine toxicity [25, 261. Renal cortical mitochon-
dna isolated from the kidneys of animals treated with cyclospo-
nine (25 mg/kg) exhibited no abnormalities in their respiratory
properties. Kidney mitochondnia isolated from animals treated
with 75 mg/kg exhibited unchanged idle respiration (state 4)
with succinate in contrast to the findings in vitro. The rate of
Data represent means 5EM from 6 experiments. The rate of swelling
is expressed in the units of optical density (OD) determined at 540 nm as
described in Methods.
a P C 0.05 vs. control
A Cyclosporine
;>?:ISM
B Verapamil
I2\S%j
C Dibucaine
I
caC
CD. 540 nm
0.20 1 mm
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ADP-stimulated respiration was markedly decreased and the
acceptor-control index was significantly lower, in agreement
with findings in vitro. Cyclosporine treatment did not alter the
ADP/0 ratio, or the respiration of mitochondria uncoupled by
CCCP or A23 187. Electron flow in the separate segments of the
mitochondrial electron transport chain was also unchanged.
Therefore, it is possible to conclude that the effect of cyclospo-
rifle in vivo (75 mg/kg) on mitochondrial respiration is compa-
rable to its effect in vitro at a concentration of about 25 to 50
nmol per mg of mitochondrial protein. These findings are in
agreement with a reported threshold level of 10 sg/ml cyclo-
sporine in vitro on mitochondrial respiration [12].
To evaluate whether cyclosporine may impair other mito-
chondrial functions, a model of spontaneous calcium discharge
was utilized [20—22]. The phenomenon of calcium-induced
swelling of mitochondria is recognized as a process of increased
non-specific permeability of the mitochondrial membrane. It is
accompanied by collapse of electrical potential, enhanced res-
piration and release of ions from the mitochondrial matrix.
Cyclosporine appeared to be a strong inhibitor of calcium-
induced swelling of renal mitochondria. Under in vitro condi-
tions, this inhibition occurred at a concentration range 100
times lower than that required to impair ADP-phosphorylation.
In vivo, it was demonstrated at an oral dose of 25 mg/kg
cyclosporine in the absence of deteriorated respiration.
It is reported that several compounds acting as potential
inhibitors of calcium-induced swelling of mitochondria inhibit
the activity of phospholipase A2 in whole mitochondria and
isolated mitochondrial membranes [24]. These are structurally
and functionally different compounds such as dibucaine, vera-
pamil, trifluoperazine, R24571 and quinacrine. Among them
verapamil and dibucaine are weak and strong inhibitors, respec-
tively. Their inhibition concentrations are in a range of iO to
i0 M [24]. In our study, cyclosporine appeared to be a much
more powerful inhibitor of calcium-induced swelling of kidney
mitochondria than either verapamil or dibucaine. Its inhibition
was in the concentration range of 10 to l0- M. Although the
swelling of mitochondria was inhibited, calcium uptake was not
affected by cyclosporine. This strongly suggests that cyclospo-
rine affects membrane permeability but not the calcium uni-
porter.
An increase in phospholipase A2 activity has been implicated
in the process of calcium-induced mitochondrial swelling, but
factors directly responsible for altered membrane permeability
still remain elusive. It is reported that cyclosporine is an
inhibitor of pancreatic phospholipase A2 [33]. However, an
increase in membrane permeability may occur independently of
an increase in phospholipase A2 activity [34]. It has been known
for many years, moreover, that other factors such as glu-
tathione reductase and catalase activity are involved in the
integrity of mitochondrial membranes [35].
The influence of cyclosporine is probably not limited to the
mitochondrial membrane, but to other cellular membranes as
well. Cyclosporine has been reported to induce lobulation in the
nuclei of human T-lymphocytes and monocytes, a property it
shares with the calmodulin antagonist R24571 [36].
The data obtained from this study indicate that cyclosporine
interacts with the membrane of renal cortical mitochondria. The
actions of cyclosporine are virtually identical under in vitro and
in vivo conditions. Diminished calcium-dependent permeability
of the mitochondrial membrane was followed by a decreased
rate of ADP-phosphorylation. These changes may be responsi-
ble for the toxic effect of cyclosporine on the kidneys.
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